Cardiovascular Pharmacotherapeutics is a compendium of valuable, updated pharmacotherapeutic information for managing patients with cardiovascular disease.

The updated Second Edition of Cardiovascular Pharmacotherapeutics covers:

• Cardiovascular agents
• Mechanisms of action of cardiovascular pharmacotherapeutics
• Specific drug treatments
• Drugs in development
• Molecular biological advances
• and more!

Cardiovascular Pharmacotherapeutics provides:

• An understanding of all presently available cardiovascular agents
• The scientific basis behind every pharmacotherapy advance
• Hands-on discussions of how to utilize specific drugs for treatment of various cardiovascular disorders and for the prevention of disease
• Information about recently approved drugs that were only pharmacologic concepts in the previous edition
• Detailed discussion of drugs in development and potential drug targets for innovative drug discovery – outgrowths of advances in knowledge of receptor and ion channel biology, cell growth, neurohumoral control, biochemistry and pathophysiology
• and more!

Contents

Part 1: Introductory Chapters

1. Basic Principles
2. Placebo Effect
3. Compliance
4. New Drug Development
5. Pharmacoeconomics
6. Cardiovascular Pharm History

Part 2 Drug Classes

7. Alpha & Beta blockers
8. Cholinergic & Anticholinergic Drugs
9. Calcium blockers
10. RAS – ACE, ARBs
11. Diuretic
12. Mag, K+, Calcium
13. Digitalis and Inotropic Agents
14. Organic Nitrates and nitroprusside
15. Central Action, Ganglionic blockers, neuron depletors
16. Nonspecific antihypertensive vasodilators
17. Antiarrhythmics
18. Antiplatelets & Antithrombotics
19. Thrombolytics
20. Lipid lowering/effects of CV drugs on lipoproteins
21. Combination
22. Smoking, nicotine
23. Fish oils
24. Antioxidant vitamins and free radical scavengers
25. Prostacyclin
26. Dopamine
27. Natriuretic peptides and neutral endopeptidase

Part 3: New Drug Classes in Development

28. Potassium channel and sodium-hydrogen channel
29. Serotonin
30. Imidazoline
31. Endothelin
32. Adenosine
33. Nitric oxide
34. Renin
35. Vasopressin
36. Hormones
37. Innovative approaches for myocardial ischemia – focus on angiogenesis
38. Angiogenesis
39. Innovative drug targets
40. Restenosis
41. Gene therapy
42. Apoptosis
43. Matrix Metalloproteinase
44. NSAIDS & Cox 2 inhibitors
45. Prostaglandins & P450 Metabolites
46. Innovative medical approaches to hyperlipidemia

Part 4: Special Topics

47. Use of alternative/complementary medicine in treaating cardiovascular disease
48. Cardiovascular drug interactions
49. Pediatric cardiovascular pharmacology
50. Drug treatment of peripheral vascular disease
51. Quality-of-life issues with cardiovascular drug therapy

Index

click here to see books • videos • cd-roms of related interest